{"id":"https://openalex.org/W2587624006","doi":"https://doi.org/10.1161/01.hyp.36.suppl_1.688-a","title":"Changes in Vsmc Phenotypes in Ang Ii-Dependent Hypertension of TGR (mREN2) 27 (Tgr) Transgenic Rats","display_name":"Changes in Vsmc Phenotypes in Ang Ii-Dependent Hypertension of TGR (mREN2) 27 (Tgr) Transgenic Rats","publication_year":2000,"publication_date":"2000-10-01","ids":{"openalex":"https://openalex.org/W2587624006","doi":"https://doi.org/10.1161/01.hyp.36.suppl_1.688-a","mag":"2587624006"},"language":"en","primary_location":{"id":"mag:2587624006","doi":"https://doi.org/10.1161/01.hyp.36.suppl_1.688-a","is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/10.1161/hyp.36.suppl_1.688-a","pdf_url":null,"source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Hypertension","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072973405","display_name":"Gian Paolo Rossi","orcid":"https://orcid.org/0000-0002-7963-0931","observed_orcids":["https://orcid.org/0000-0002-7963-0931","https://orcid.org/0000-0002-4937-7744"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gian Paolo P Rossi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105361315","display_name":"Saverio Sartore","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saverio Sartore","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069910115","display_name":"Stefania Colonna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S Colonna","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024377944","display_name":"Alfredo Sacchetto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alfredo Sacchetto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075108700","display_name":"Giorgio Rizzoni","orcid":"https://orcid.org/0000-0002-8397-7241","observed_orcids":["https://orcid.org/0000-0002-8397-7241"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giorgio Rizzoni","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-8397-7241","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046529833","display_name":"Giuseppina Mazzocchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giuseppina Mazzocchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103431000","display_name":"Anna Sandra Belloni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna S. Belloni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111616132","display_name":"Gastone Giovanni Nussdorfer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gastone G. Nussdorfer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5031504457","display_name":"Achille Cesare Pessina","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Achille C. Pessina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.39863198,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"36","issue":null,"first_page":"688","last_page":"688"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.8134999871253967,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.13050000369548798,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.026599999517202377,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vascular-smooth-muscle-cell-phenotype","display_name":"vascular smooth muscle cell phenotype","score":0.8180000185966492},{"id":"https://openalex.org/keywords/angiotensin-ii-induced-hypertension","display_name":"angiotensin II-induced hypertension","score":0.9049999713897705},{"id":"https://openalex.org/keywords/endothelin-1","display_name":"endothelin-1","score":0.9350000023841858},{"id":"https://openalex.org/keywords/endothelin-a-receptor","display_name":"ETA receptor","score":0.7689999938011169},{"id":"https://openalex.org/keywords/endothelin-b-receptor","display_name":"endothelin B receptor","score":0.9509999752044678},{"id":"https://openalex.org/keywords/irbesartan","display_name":"irbesartan","score":0.8100000023841858},{"id":"https://openalex.org/keywords/bosentan","display_name":"bosentan","score":0.9509999752044678},{"id":"https://openalex.org/keywords/angiotensin-ii-type-1-receptor","display_name":"angiotensin II type 1 receptor","score":0.527999997138977},{"id":"https://openalex.org/keywords/vascular-hypertrophy","display_name":"vascular hypertrophy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/smooth-muscle-myosin-heavy-chain","display_name":"smooth muscle myosin heavy chain","score":0.652999997138977},{"id":"https://openalex.org/keywords/mesenteric-arterioles","display_name":"mesenteric arterioles","score":0.8090000152587891},{"id":"https://openalex.org/keywords/iliac-artery","display_name":"iliac artery","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.823138415813446},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.8129167556762695},{"id":"https://openalex.org/C2780259554","wikidata":"https://www.wikidata.org/wiki/Q947266","display_name":"Irbesartan","level":3,"score":0.7625119686126709},{"id":"https://openalex.org/C2781109936","wikidata":"https://www.wikidata.org/wiki/Q419769","display_name":"Bosentan","level":4,"score":0.7215025424957275},{"id":"https://openalex.org/C2779941686","wikidata":"https://www.wikidata.org/wiki/Q6947930","display_name":"Myograph","level":3,"score":0.6774464845657349},{"id":"https://openalex.org/C2779395532","wikidata":"https://www.wikidata.org/wiki/Q7916469","display_name":"Vascular smooth muscle","level":3,"score":0.662804126739502},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.5435282588005066},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.5031251311302185},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5019562244415283},{"id":"https://openalex.org/C144980905","wikidata":"https://www.wikidata.org/wiki/Q24721308","display_name":"Endothelin receptor","level":3,"score":0.47190243005752563},{"id":"https://openalex.org/C167414201","wikidata":"https://www.wikidata.org/wiki/Q1955391","display_name":"Muscle hypertrophy","level":2,"score":0.4693302512168884},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44394057989120483},{"id":"https://openalex.org/C149601957","wikidata":"https://www.wikidata.org/wiki/Q390566","display_name":"Endothelin 1","level":3,"score":0.4247214198112488},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4126951992511749},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32471662759780884},{"id":"https://openalex.org/C120770815","wikidata":"https://www.wikidata.org/wiki/Q14859627","display_name":"Vasodilation","level":2,"score":0.304776132106781},{"id":"https://openalex.org/C2992686903","wikidata":"https://www.wikidata.org/wiki/Q208453","display_name":"Smooth muscle","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2587624006","doi":"https://doi.org/10.1161/01.hyp.36.suppl_1.688-a","is_oa":false,"landing_page_url":"https://www.ahajournals.org/doi/10.1161/hyp.36.suppl_1.688-a","pdf_url":null,"source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Hypertension","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2032107784","https://openalex.org/W2123872592","https://openalex.org/W2080881690","https://openalex.org/W2317989486","https://openalex.org/W2079013938","https://openalex.org/W3173404325","https://openalex.org/W2010655984","https://openalex.org/W2028868312","https://openalex.org/W2037941010","https://openalex.org/W4293153986"],"abstract_inverted_index":{"57":[0],"Arterial":[3],"hypertension":[4,40,252],"is":[5,25,255],"associated":[6,257],"with":[7,158,162,258],"vascular":[8,260],"smooth":[9,176],"muscle":[11,177],"cells":[12],"(VSMC)":[13],"phenotypic":[14,228],"differentiation,":[15],"but":[16,238,280],"the":[17,31,42,81,96,111,140,150,152,241],"role":[18,43],"of":[19,33,44,126,166,253,265],"Ang":[20,38,97,250],"II":[21,98],"and":[23,41,46,66,70,131,143,190,199,236,262,276],"ET-1":[24,45],"still":[26],"unclear.":[27],"Thus,":[28,249],"we":[29],"investigated":[30],"changes":[32,155],"VSMC":[34,227,266],"phenotypes":[36],"in":[37],"II-dependent":[39,251],"its":[48],"A":[49,52,85,113,173,224,243,284],"receptor":[50,101],"(ET":[51],").":[53],"Four-week":[54],"old":[55],"heterozygote":[56],"male":[57],"TGR":[58,254],"rats":[60,206,219],"(n=24)":[61],"were":[62,134,138,147,156,207],"body":[63],"weight":[64],"(BW)-":[65],"blood":[67],"pressure":[68],"(BP)-matched":[69],"randomly":[72],"allocated":[73],"to":[74,213],"receive":[75],"orally":[76],"a":[77,159,163,263,268],"placebo":[78],"(Group":[79],"P),":[80],"mixed":[82],"ET":[84,112,172,242,277,283],"/ET":[86],"B":[87,278],"antagonist":[89,102,116,246],"Bosentan":[90],"(100":[91],"mg/Kg,":[92],"Group":[93,108,122,217],"B)":[95],"AT-1":[99],"specific":[100,169],"Irbesartan":[103],"(50":[104],"mg/Kg":[105,120],"BW,":[107,121],"I)":[109],"or":[110],"selective":[115],"BMS-182874":[117],"(52":[118],"BMS).":[123],"After":[124],"4-wk":[125],"treatments,":[127],"during":[128],"which":[129,272],"BW":[130],"BP":[132],"measured":[135],"weekly,":[136],"animals":[137],"euthanized;":[139],"iliac":[141],"artery":[142],"mesenteric":[145],"arterioles":[146],"collected.":[148],"In":[149],"latter":[151],"structural":[153],"assessed":[157],"myograph.":[160],"Immunohistochemistry":[161],"panel":[165],"different":[167],"antibodies":[168],"for":[170],"ET-1,":[171],",":[174],"(SM)":[178],"myosin,":[179],"SM":[180,182],"actin,":[181],"22,":[183],"myosin":[184],"heavy":[185],"chains":[186],"Apla":[187],"22":[188],"fibronectin":[191],"EIIIA":[192],"was":[193,230],"carried":[194],"out.":[195],"The":[196,226],"fetal,":[197],"neonatal":[198],"adult":[200],"aorta":[202],"from":[203],"normotensive":[204],"Sprague-Dawley":[205],"studied":[208],"as":[209],"control.":[210],"Compared":[212],"all":[214],"other":[215],"groups,":[216],"I":[218],"showed":[220],"significantly":[221],"(p":[223],".":[225],"shift":[229,264],"prevented":[231],"by":[232,240],"both":[233,259],"irbesartan":[235],"Bosentan,":[237],"not":[239,282],"-selective":[244],"BM":[247],"182874.":[248],"hypertrophy":[261],"toward":[267],"fetal":[270],"phenotype,":[271],"occurs":[273],"through":[274],"AT-1-":[275],"-":[279],"-mediated":[285],"mechanisms.":[286]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2017-02-17T00:00:00"}